CR7060A - PREGABALINE-LACTOSE CONJUGATES - Google Patents

PREGABALINE-LACTOSE CONJUGATES

Info

Publication number
CR7060A
CR7060A CR7060A CR7060A CR7060A CR 7060 A CR7060 A CR 7060A CR 7060 A CR7060 A CR 7060A CR 7060 A CR7060 A CR 7060A CR 7060 A CR7060 A CR 7060A
Authority
CR
Costa Rica
Prior art keywords
lactose
disorders
pregabaline
pregabalin
disorder
Prior art date
Application number
CR7060A
Other languages
Spanish (es)
Inventor
Robert Hurley Timothy
James Lovdahl Michael
Tobias Brian
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Priority to CR7060A priority Critical patent/CR7060A/en
Publication of CR7060A publication Critical patent/CR7060A/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se proporcionan compuestos conjugados de pregabalina-lactosa, tambien se proporciona como parte de la presente invencion un nuevo metodo para tratar en un sujeto trastornos o enfermedades del sistema nervioso central, que incluyen trastornos o crisis convulsivas, dolor, depresion, ansiedad, trastornos del sueno, trastornos consuntivos, psicosis, discinesia tardia, enfermedades de Huntington o Parkinson, administrando al sujeto una cantidad farmaceuticamente eficaz de un conjugado de pregabalina lactosa.Conjugated pregabalin-lactose compounds are provided, a new method for treating a central nervous system disorder or disorder, including seizure disorders or seizures, pain, depression, anxiety, sleep disorders, is also provided as part of the present invention. , consumptive disorders, psychosis, tardive dyskinesia, Huntington's or Parkinson's diseases, administering to the subject a pharmaceutically effective amount of a pregabalin lactose conjugate.

CR7060A 2003-08-26 2003-08-26 PREGABALINE-LACTOSE CONJUGATES CR7060A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CR7060A CR7060A (en) 2003-08-26 2003-08-26 PREGABALINE-LACTOSE CONJUGATES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CR7060A CR7060A (en) 2003-08-26 2003-08-26 PREGABALINE-LACTOSE CONJUGATES

Publications (1)

Publication Number Publication Date
CR7060A true CR7060A (en) 2004-02-23

Family

ID=44839116

Family Applications (1)

Application Number Title Priority Date Filing Date
CR7060A CR7060A (en) 2003-08-26 2003-08-26 PREGABALINE-LACTOSE CONJUGATES

Country Status (1)

Country Link
CR (1) CR7060A (en)
  • 2003

Similar Documents

Publication Publication Date Title
DOP2002000356A (en) CONJUGADOS DE PREGABALINA LACTOSA
ES2156162T3 (en) ACTIVE COMPOUNDS IN A NEW SITE ON CALCIUM CHANNELS OPERATED BY A RECEIVER, USEFUL FOR THE TREATMENT OF DISORDERS AND NEUROLOGICAL DISEASES.
DE60044152D1 (en) Bupropion metabolite for the treatment of anxiety
BR0316438A (en) Erythropoietin use in heart disease
HN2001000037A (en) DERIVATIVES OF ETERES DE PIRAZOL AS ANTI-INFLAMMATORY / ANALGESIC AGENTS
BRPI0408026A (en) Quinazolines useful as ion channel modulators
BRPI0811956A8 (en) TOPICAL NON-AQUEOUS DICLOFENAC SOLUTION AND PROCESS FOR ITS PREPARATION
MX2010009767A (en) Use of mesenchymal stem cells for treating genetic diseases and disorders.
BR0108977A (en) Azacyclic compounds for use in the treatment of serotonin-related diseases
ES2144623T3 (en) DAILY BICYCLE HETERO CYCLES AS CYCLOOXYGENASE-2 INHIBITORS.
HN1999000015A (en) TREATMENT FOR A FEMALE SEXUAL DYSFUNCTION
CU23167A3 (en) INHIBITORS OF THE RECOVERY OF MONOAMINS FOR THE TREATMENT OF CNS DISORDERS
ES2195943T3 (en) BICYCLE AND TRICICLIC HETEROAROMATIC COMPOUNDS.
NO2012015I2 (en) Dapoxetine
MA31849B1 (en) New pyrimidine derivatives
PA8597301A1 (en) DERIVATIVES OF IMIDAZOL-4-IL-ETINIL-PIRIDINA
GT200500086A (en) ESTEREOSELECTIVE BIOCONVERSION OF ALIFATIC DINITRILS IN CYANOCARBOXYL ACIDS.
MX2010003603A (en) Method of treating polycystic kidney diseases with ceramide derivatives.
WO2004017904A3 (en) Corticosteroid conjugates and uses thereof
PL1976544T3 (en) Method of using guava extract and composition including guava extract
CY1109666T1 (en) METHOD OF THERAPEUTIC AND RACOIDIS DISEASE TREATMENT
CR7060A (en) PREGABALINE-LACTOSE CONJUGATES
AU2003277280A1 (en) Biphenyls and fluorenes as imaging agents in alzheimer's disease
WO2004092379A3 (en) Method for treatment of angiogenic disorders
DK1641775T3 (en) 2-pyridinal pine derivatives useful for the treatment of pain

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)